More recently, Gal1 was shown to upregulate expression of programmed death ligand 1 (PD-L1) in tumor endothelium, thereby inducing an immune-suppressive barrier and prevention of T cell migration into the tumor [14]. Here, LGALS1 is linked to neoplasm.